"Orosomucoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D009961
|
| MeSH Number(s) |
D12.776.124.050.600 D12.776.124.790.106.640 D12.776.377.715.085.640 D12.776.395.560.742
|
| Concept/Terms |
Orosomucoid- Orosomucoid
- Acid Seromucoid
- Seromucoid, Acid
- Acid alpha 1-Glycoprotein
- Acid alpha 1 Glycoprotein
- alpha 1-Glycoprotein Acid
- alpha 1 Glycoprotein Acid
- alpha 1-Acid Seromucoid
- Seromucoid, alpha 1-Acid
- alpha 1 Acid Seromucoid
- alpha 1-Acid Glycoprotein
- Glycoprotein, alpha 1-Acid
- alpha 1 Acid Glycoprotein
- Seromucoid
- Serum Sialomucin
- Sialomucin, Serum
- A(1)-Acid Seromucoid
- Alpha(1)-Acid Glycoprotein
|
Below are MeSH descriptors whose meaning is more general than "Orosomucoid".
Below are MeSH descriptors whose meaning is more specific than "Orosomucoid".
This graph shows the total number of publications written about "Orosomucoid" by people in this website by year, and whether "Orosomucoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Orosomucoid" by people in Profiles.
-
The Hepatokine Orosomucoid 2 Mediates Beneficial Metabolic Effects of Bile Acids. Diabetes. 2024 May 01; 73(5):701-712.
-
The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation. Biochem Biophys Res Commun. 2021 01 01; 534:864-870.
-
Pharmacokinetics of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally advanced or metastatic solid tumors: the role of alpha-1-acid glycoprotein binding. Clin Cancer Res. 2011 Apr 15; 17(8):2512-20.
-
Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia. Leukemia. 2009 Sep; 23(9):1537-44.
-
Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int. 2004 Apr; 65(4):1408-15.
-
The acute-phase protein response to infection in edematous and nonedematous protein-energy malnutrition. Am J Clin Nutr. 2002 Dec; 76(6):1409-15.
-
Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002 Jun; 61(6):2240-9.
-
Acute-phase protein response to infection in severe malnutrition. Am J Physiol. 1998 07; 275(1):E112-7.
-
Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc Natl Acad Sci U S A. 1993 Dec 15; 90(24):11548-52.
-
The v-raf oncogene enhances tumorigenicity and suppresses differentiation in vivo in a rat hepatocyte cell line. Carcinogenesis. 1993 Apr; 14(4):669-74.